Cases of overdose have been reported during post-marketing surveillance after administration of Twinrix according to a three doses schedule. Adverse events reported following overdosage were similar to those reported with normal vaccine administration.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
